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Abstract To elucidate the role of nitric oxide (NO) in the 
metabolisms of enteric bacteria, its effect on the respiration and 
growth of Escherichia coli was examined. Respiration of E. coli 
was reversibly inhibited by N O particularly under low oxygen 
tensions. Growth of E. coli was also inhibited by N O more 
strongly under low oxygen tension than at its high concentration. 
Because the intestinal lumen is anaerobic, even a small amount of 
NO might strongly inhibit the energy metabolism and growth of 
E. coli and other enteric bacteria in vivo than in air atmospheric 
conditions in which oxygen tension is unphysiologically high. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Nitric oxide (NO) is a short-lived gaseous radical synthe-
sized by N O synthase (NOS) and has a wide variety of func-
tions, such as vasodilatation, neuronal transmission, and in-
hibition of leukocyte adhesion and platelet aggregation [1]. 
Recent studies revealed the presence of several N O S isozymes, 
such as the constitutive type enzyme (cNOS) in vascular en-
dothelial cells [2] and N O neurons [3] and the inducible type 
enzyme (iNOS) in macrophages [4] and neutrophils [5]. It has 
been reported that N O derived from activated macrophages 
and neutrophils exhibits bactericidal and tumoricidal actions 
[6-8]. The effects of N O are mediated, at least in part, through 
interaction with iron-sulfur clusters and heme-containing en-
zymes [9]. N O also inhibits ribonucleotide reducíase thereby 
suppressing D N A replication [10]. 
Because N O also reacts rapidly with other compounds, such 
as O2, Superoxide radicals and thiols, its fate and functions 
might be affected by these reactants. In fact, the lifetime of 
N O is fairly short under air atmospheric conditions (ca. sev-
eral seconds) predominantly due to rapid reaction with mo-
lecular oxygen (k= 6X 106 M~ 2 s_ 1) [11]. Thus, the lifetime of 
N O and its functions might differ significantly depending on 
the oxygen tensions in and around cells and tissues. Although 
effects of N O on various functions of enteric bacteria have 
been studied extensively [12-14], most of in vitro experiments 
were carried out under air atmospheric conditions in which 
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oxygen concentration is significantly higher than those in vivo. 
Because the intestinal lumen is anaerobic, in vivo effects of 
N O on the metabolism of enteric bacteria might be stronger 
than those expected from in vitro experiments performed 
under non-physiologically high oxygen tensions. The present 
work describes the effect of N O on the respiration and growth 
of E. coli under different oxygen tensions. 
2. Materials and methods 
2.1. Chemicals 
NO and argon gases were obtained from Kinkisanki Co. (Osaka). 
7Y-Ethyl-2-(l-ethyl-2-hydroxy-2-nitrosohydrazino)-ethanamine 
(NOC12) was purchased from Dojindo Co. (Kumamoto, Japan). All 
reagents used were of analytical grade and obtained from Sigma 
Chemical Co. (St. Louis, MO). 
2.2. Preparation of NO solution 
NO solution was prepared after bubbling NO gas through 50 mM 
HEPES-NaOH buffer, pH 7.4, as described previously [15]. Two 
small tubes were fitted with an air-tight septum with glass tubes in-
serted for delivery and escape of gases with a first tube containing 5 M 
KOH and a second tube containing the HEPES-NaOH buffer. Argon 
was delivered into two tubes at a flow rate of 100 ml/min. After 
15 min, argon was replaced with NO at a flow rate of 100 ml/min. 
After 15 min, the saturated NO solution (1.9 mM) was kept on ice 
and used for experiments within 3 h; the concentration of NO in the 
stock solution remained unchanged during the experiments. 
2.3. Bacteria 
E. coli K12 strain JM 109 was used throughout the experiments. 
E. coli was cultured at 37°C in LB broth. All solutions were sterilized 
by autoclaving. One-hundred microlitres of an overnight broth culture 
was inoculated into a 50 ml flask containing 10 ml of nutrient broth 
and incubated at 37°C with shaking for 5-6 h. Early-log-phase cul-
tures were obtained as described previously [16]. All experiments were 
performed using E. coli at this phase. Cultured cells were centrifuged 
at 3000 Xg and 4°C for 10 min, washed once with 10 ml of saline, and 
resuspended in LB broth at a titer of 1 X 105 colony-forming units 
(CFU)/ml. An optical density (OD) of 0.1 at 550 ran corresponds to 
approximately 1 X 108 CFU/ml. Growth curves were determined by 
subculturing LB broth both in air atmospheric conditions and at 
low oxygen tension (25 μΜ). 
2.4. Analysis of oxygen consumption 
Oxygen consumption by E. coli (1X108 cells/ml) was determined 
polarographically using a Clark type oxygen electrode fitted to a 2 ml 
water-jacketed closed chamber [17]. Cellular respiration was measured 
at 37°C in HEPES-KRP (50 mM HEPES, pH 7.4, 100 mM NaCl, 
5 mM KC1, 1 mM each of MgCl2, NaH 2P0 4 , D-glucose and CaCl2). 
Aliquots of an NO-saturated solution were added to the reaction 
mixture at varying oxygen tensions. 
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Fig. 1. Effect of NO and oxygen on the respiration of E. coli. E. coli (1 X 108 cells/ml) were incubated in a closed chamber containing 2 ml of 
HEPES-KRP (pH 7.4) at 37°C. At the indicated times (arrows), NO was added to the reaction mixture to give a final concentration of 5 μΜ. 
During the incubation, the oxygen consumption in the medium was monitored as described in the text. Inset shows the effect of oxygen tension 
on the time required for the disappearance of the inhibitory effect of NO (mean ± SE). The experiments were carried out at least 5 times with 
similar results. 
3. Result 
3.1. Effect of NO and oxygen tension on the respiration of 
E. coli 
E. coli revealed a marked respiration in the culture medium 
as measured by an oxymeter. Cellular respiration was tran-
siently inhibited by a low concentration of NO and recovered 
completely after certain periods of incubation (Fig. 1). The 
inhibitory effect of NO significantly increased with concomi-
tant decrease in oxygen tension. The inhibitory effect of NO 
depended on its concentration both at high and low oxygen 
tensions (Fig. 2). The time required for the recovery of the 
respiration depended on the concentrations of both NO and 
oxygen (Fig. 3). 
3.2. Effects of NO metabolites and hemoglobin on the 
respiration of E. coli 
To elucidate the possible involvement of NO metabolites in 
the inhibition of E. coli respiration, effect of nitrite and nitrate 
on cellular respiration was examined (Fig. 4). A fairly high 
concentration (100 μΜ) of both nitrite and nitrate had no 
appreciable effect on the respiration of E. coli at any oxygen 
concentrations tested. 
Because NO has an extremely high affinity for oxyhemoglo-
bin (Hb02), this protein has been used for testing the speci-
ficity of NO action. To elucidate the inhibitory mechanism of 
NO, its effect was also studied in the presence of either eryth-
rocytes or Hb0 2 . A fairly small amount of erythrocytes (1.0% 
hematocrit) completely reversed the respiration inhibited by 
NO. The inhibitory effect of NO was also suppressed by 
Hb02 in a dose-dependent manner. An equimolar concentra-
tion of Hb02 completely blocked the inhibitory effect of NO. 
3.3. Effect of NO and oxygen tension on the growth of E. coli 
NOCÍ2 spontaneously and stoichiometrically releases NO 
(1.5 mol NO from 1 mol of the agent) and, hence, this com-
pound has been used as an useful NO donor. The growth of 
E. coli was inhibited by the presence of NOC12 (Fig. 5). The 
inhibitory effect depended on the concentration of NOC12. 
Again, the inhibitory effect of NOCÍ2 was significantly 
stronger under low oxygen tension than under air atmospheric 
conditions. 
4. Discussion 
The present work demonstrates that NO but not nitrite and 
nitrate reversibly inhibited the respiration of E. coli in a con-
centration-dependent manner by some mechanism which was 
suppressed by either erythrocytes or HbOi. The inhibitory 
effect of NO lasted significantly longer under low oxygen ten-
sions than at its high concentrations. Preliminary experiments 
revealed that similar doses ( ~ 10 μΜ) of peroxynitrite had no 
appreciable effect on the respiration of E. coli. These results 
indicate that NO rather than its reactive metabolites is respon-
sible for the reversible inhibition of cellular respiration. Con-
sistent with this notion is the reports that NO reversibly in-
teracts with cytochrome c oxidase and other proteins in the 
electron transport systems thereby inhibiting the respiration 
and energy transduction of mitochondria [18,19] and ascites 
tumor cells [20,21]. The effects of NO on other functions of 
cells and tissues also increased with concomitant decrease in 
oxygen tensions [19-21]. Thus, NO effects are principally 
stronger under physiologically low oxygen tensions than pre-
viously expected from in vitro experiments performed under 
air atmospheric conditions. Because the origin of mitochon-
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Fig. 2. Dose-dependent inhibition of E. coli respiration at different oxygen tensions. At oxygen tensions of 150 (A) and 40 μΜ (Β), NO was 
added to the reaction mixture to give final concentrations of 0 (1), 2.5 (2), 5 (3), 10 (4) and 20 μΜ (5). Other conditions were as descried in 
Fig. 1. Each experiment was carried out at least 5 times with similar results. 
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dria has been postulated to be some bacteria with aerobic 
nature [22], it is not surprising that the respiration of both 
mitochondria and E. coli was inhibited by NO in a similar 
fashion. 
The present work also demonstrates that the growth of E. 
coli was inhibited by NOCÍ2 more strongly under low oxygen 
tensions than under air atmospheric conditions. Although, the 
lifetime of NO has been postulated to be extremely short 
(several seconds) particularly under air atmospheric condi-
tions [11], NO is fairly stable under low oxygen tensions 
Fig. 3. Effect of oxygen tension on the inhibitory effect of NO. NO 
was added to the incubation mixtures at oxygen tension of 40 (o) 
or 150 μΜ (D). Effect of oxygen tension on the time required for 
the disappearance of the inhibitory effect of NO (mean±SE) was 
shown. Other conditions were the same as in Fig. 2. 
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Fig. 4. Effect of NO metabolites and hemoglobin on the respiration. At the indicated times, either 100 μΜ of nitrite, nitrate or 10 μΜ of NO 
was added to the reaction mixture. Then, either erythrocytes (RBC, 1.0% hematocrit) or oxyhemoglobin (Hb) was added to the reaction mix-
ture. The final concentrations of Hb were 0 (1), 2.5 (2), 5 (3), and 10 μΜ (4). The experiments were carried out at least 3 times with similar re-
sults. 
[21]. This might be one of the reason why NO strongly in-
hibited the respiration and growth of E. coli under low oxygen 
tensions. 
It should be noted that oxygen is the substrate for NOS 
and, hence, the rate of NO synthesis may decrease under low 
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Fig. 5. Effect of NO and oxygen concentration on cell growth. E. 
coli were cultured at 37°C in 10 ml of LB broth either under air at-
mospheric conditions (o) or under 25 μΜ oxygen (·). The growth 
of E. coli was determined by measuring optical density at 550 nm. 
An OD value of 0.1 corresponded to approximately lXlO8 CFU/ 
ml. The concentrations of NOC12 used were 0 (0), 0.05 (1) and 
0.3 mM (2). The experiments were carried out at least 3 times with 
similar results. The insert shows % inhibition of the growth by 
NOC12 at 7 h (mean+SE). 
oxygen tensions. Thus, the enhancement of NO action by low 
oxygen tensions might not occur in completely anaerobic 
compartments, such as in the large intestinal lumen, where 
substrate oxygen for NOS is lacking. In this context, the Km 
value of iNOS for molecular oxygen has been reported to be 
about 6.3 ±0.9 μΜ [23]. Therefore, macrophages and neutro-
phils not only in the circulation but also in the interstitial 
space of the intestine might generate reactive oxygen species 
including NO [24]. Furthermore, because of gaseous nature of 
NO, it might easily diffuse from the site of generation in in-
testinal walls into their lumenal compartments. Thus, NO 
generated by the activated leukocytes in an inflammatory le-
sion of the intestine might reach to its lumenal space where a 
large number of enteric bacteria are living. 
Although cNOS has been reported to localize in gastroin-
testinal tracts, such as in myenteric plexus [25] and epithelial 
cells [26], enteric activity of iNOS in normal subjects is low. 
However, iNOS is induced in macrophages and neutrophils 
which are stimulated by various ligands including bacterial 
lipopolysaccharide (LPS) and inflammatory cytokines. In 
fact, patients with inflammatory bowel disease, such as ulcer-
ative colitis and Crohn's disease, have high activity of iNOS in 
the large intestine [27,28]. Furthermore, plasma levels of ni-
trite and nitrate in these patients are significantly higher than 
those in normal subjects. Although NO derived from inflam-
matory cells often increases vascular permeability and tissue 
injury, it principally plays protective roles in host defense 
mechanism against bacterial translocation [29-32]. Prelimi-
nary experiments revealed that the sensitivity of bacteria to 
NO might seem to differ from one species to another. Thus, 
NO might play important roles in the regulation of metabo-
lisms and growth of NO-sensitive bacteria in the anaerobic 
lumen of gastrointestinal tracts. The mechanism by which 
NO inhibits respiration and cell growth of E. coli should be 
studied further. 
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